DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

More Magazine Features

In nuclear medicine, scanners get more sensitive, software more specific What's new in PET and SPECT?

Installing and removing imaging equipment is no small task Expert insights on how project management is evolving

Informatics, standardization and the next phase for enterprise imaging Life after silos is coming into focus

Patient monitors help hospitals do more with less The latest monitors focus on workflow, EHR integration and remote capabilities

Tips for creating better collaboration between HTM and IT Streamlining these increasingly complex partnerships

See All Magazine Features  

Molecular Imaging Homepage

Mobile PET relieves hardship for rural cancer patients Mobile PET isn't just good medicine, it's good business

In nuclear medicine, scanners get more sensitive, software more specific What's new in PET and SPECT?

US suppliers to join the Mo-99 market, high-energy materials gaining traction Radiopharmaceutical supply chain update

Navigating the molecular imaging market Purchasing insights from the experts at MD Buyline

Absolute Imaging Solutions acquires Northeast Electronics Facilitates push into East Coast market

Eden Radioisotopes scores funding for isotope reactor production Will primarily produce Mo-99

SHINE secures rights to new method for Lutetium-177 production Generate Lu-177 at greater speed and scale

FDA gives green light to new United Imaging PET/MR scanner The uPMR 790 HD TOF performs total-body scans within 20 minutes

FDA reminder for properly eluting rubidium 82 generators prompted by 'recent incidents' Using incorrect solutions puts patients at risk

Generating higher quality PET images 100x faster at MSK 'No one has done PET imaging in this way before'

Assessing the state of Alzheimer’s imaging

by John R. Fischer , Staff Reporter
From the June 2019 issue of DOTmed HealthCare Business News magazine

Care for Alzheimer’s patients in the U.S. is estimated to reach $1.1 trillion in Medicare and Medicaid costs by 2050 if a treatment, or cure, is not found, according to the Alzheimer’s Association. With over 27 million cases worldwide, the neurodegenerative disease touches many lives and the demand for better care has never been greater.

Medical imaging has shown promise in recent years for visualizing the way Alzheimer’s spreads and opening up a greater understanding of the condition. Using biomarkers, researchers aim to widen the scope of diagnostic options available and facilitate earlier detection of the disease.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



“Biomarkers for amyloid and tau are necessary for positively diagnosing Alzheimer’s in a patient. It takes time for biomarkers to be recognized and accepted, first by the scientific community, then by the clinical community, and eventually, bodies such as CMS and private insurers for reimbursement,” Carlo Medici, CEO of Alzeca Biosciences told HCB News. “But we’re in a phase now where the need for biomarkers is increasingly recognized by the scientific community. So, there will be more research, more publications and more validation of these biomarkers.”

Earlier detection is a key focus for Alzeca, which is currently developing two new MR imaging agents for detection, one for amyloid plaques, the other for tau tangles.

But developing these markers means facing financial and regulatory obstacles while demonstrating that all these efforts will ultimately help move the needle on solving a global problem.

Three types of biomarkers
Years of research around the presence of amyloid plaques and its association with Alzheimer’s has led to the development of diagnostic agents that have earned approval from the FDA. A shift, however, is now underway from amyloid-centric to non-amyloid imaging targeting, especially around tau tangles, which must be present alongside amyloid plaques to confirm a diagnosis of Alzheimer’s.

“These changes in the brain occur 15-20 years before the onset of clinical symptoms. A patient may have amyloid plaques in the brain, without having any symptoms whatsoever,” said Medici. “So, the presence of the plaques does not necessarily mean they’ll develop dementia due to Alzheimer’s. It’s the beginning of what I call a physiopathological journey that could lead to dementia.”

One biomarker included in the classification of Alzheimer’s is neurodegeneration, which is characterized by the destruction of neurons and synapses that connect various neurons to one another. These are associated with amyloid plaques and tau tangles.
  Pages: 1 - 2 - 3 - 4 >>

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED